Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Voriconazole Eye Drops: A Revolutionary Approach for Treating Fungal Keratitis

Naomi Morgan

Fungal keratitis is a severe and potentially sight-threatening infection of the cornea caused by various species of fungi. It poses a significant challenge to ophthalmologists due to its aggressive nature and resistance to conventional treatments. In recent years, Voriconazole eye drops have emerged as a promising therapy for fungal keratitis, offering improved efficacy and better patient outcomes. This article explores the use of Voriconazole eye drops as a treatment option for fungal keratitis, highlighting its mechanism of action, effectiveness, and safety profile. Voriconazole is a novel antifungal agent with excellent broad spectrum activity commercially available for oral and intravenous administration. The purpose of this study was to prepare ophthalmic formulation of hydroxypropyl beta cyclodextrin based voriconazole containing benzalkonium chloride BAK and EDTA with or without viscosity modifiers and study its permeation characteristics through freshly excised goat cornea.